Hyaluronan (HA) is an essential glycosaminoglycan in the extracellular matrix that gets broken down during inflammation. Breakdown of HA leads to the eventual production of eicosanoids, which are lipid mediators also associated with chronic and acute inflammation. In this Paper of the Week, a team led by James H. Shelhamer at the National Institutes of Health worked out the molecular details of how HA fragments lead to production of lipid mediators. They demonstrated that in human monocytes and macrophages, low molecular weight HA stimulated release of arachidonic acid, a key precursor to several classes of lipids. The investigators also showed that low molecular weight HA promoted the phosphorylation of a number of enzymes, including cytosolic phospholipase A 2 group IVA (cPLA 2 ␣), which liberates arachidonic acid from cell membranes, leading to the production of eicosanoids. Fragmented HA also polarized macrophages toward a proinflammatory M1 phenotype with a unique eicosanoid profile. The authors conclude, "These findings reveal a novel link between HAmediated inflammation and lipid metabolism." DOI 10.1074/jbc.P113.515106 4489 A, proposed model of HA-induced cPLA 2 ␣ activation and eicosanoid production in monocytes and macrophages. B, impact on macrophage polarization and acquiring an eicosanoid-specific profile.
